(Q36208652)

12 August 2017

Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia (English)

1 reference

12 August 2017

1 reference

Malachi Griffith

3

0 references

Christopher A. Miller

object named as

Christopher A Miller

2

0 references

Obi Griffith

object named as

Obi L Griffith

15

0 references

Catrina Fronick

21

object named as

Catrina Fronick

1 reference

12 August 2017

33

Elaine R Mardis

1 reference

12 August 2017

29

Timothy A Graubert

1 reference

12 August 2017

13

Jack Baty

1 reference

12 August 2017

17

Jasreet Hundal

1 reference

12 August 2017

7

Lukas D Wartman

1 reference

12 August 2017

12

Jacqueline E Payton

1 reference

12 August 2017

9

Tamara L Lamprecht

1 reference

12 August 2017

Jeffery M Klco

1

1 reference

12 August 2017

Allegra Petti

4

1 reference

12 August 2017

David H Spencer

5

1 reference

12 August 2017

Shamika Ketkar-Kulkarni

6

1 reference

12 August 2017

Matthew Christopher

8

1 reference

12 August 2017

Nicole M Helton

10

1 reference

12 August 2017

Eric J Duncavage

11

1 reference

12 August 2017

Sharon E Heath

14

1 reference

12 August 2017

Dong Shen

16

1 reference

12 August 2017

Gue Su Chang

18

1 reference

12 August 2017

Robert Fulton

19

1 reference

12 August 2017

Michelle O'Laughlin

20

1 reference

12 August 2017

Vincent Magrini

22

1 reference

12 August 2017

Ryan T Demeter

23

1 reference

12 August 2017

David E Larson

24

1 reference

12 August 2017

Shashikant Kulkarni

25

1 reference

12 August 2017

Bradley A Ozenberger

26

1 reference

12 August 2017

John S Welch

27

1 reference

12 August 2017

Matthew J Walter

28

1 reference

12 August 2017

Peter Westervelt

30

1 reference

12 August 2017

Jerald P Radich

31

1 reference

12 August 2017

Daniel C Link

32

1 reference

12 August 2017

John F DiPersio

34

1 reference

12 August 2017

Richard K Wilson

35

1 reference

12 August 2017

Timothy J Ley

36

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2015

1 reference

The Journal of the American Medical Association

12 August 2017

1 reference

12 August 2017

314

1 reference

12 August 2017

8

1 reference

12 August 2017

811-822

1 reference

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Functional heterogeneity of genetically defined subclones in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Minimal residual disease in acute myeloid leukaemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Minimal residual disease in acute myeloid leukemia: coming of age.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Abnormal Cytogenetics at Date of Morphologic Complete Remission Predicts Short Overall and Disease-Free Survival, and Higher Relapse Rate in Adult Acute Myeloid Leukemia: Results From Cancer and Leukemia Group B Study 8461

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26305651

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic index for adult patients with acute myeloid leukemia in first relapse

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26305651

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Persistence ofDNMT3Amutations at long-term remission in adult patients with AML

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26305651

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1001/JAMA.2015.9643

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

26305651

1 reference